Neurology in Chester, PA
10 verified neurology doctors in Chester.
Neurologists diagnose and treat disorders of the brain, spinal cord, and nervous system, such as migraines, epilepsy, and stroke.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Pennsylvania State Board of Medicine
Dr. David Sirken, DO
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Paul Shneidman, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sudhir Stokes, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Norman Leopold, DO
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Pasquale Brancazio, DO
Neurology
CMS Open Payments· $181.81 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$181.81
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Pasquale Brancazio do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Bradley Grayum, MD
Neurology
CMS Open Payments· $14.35 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$14.35
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 50th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Bradley Grayum do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Annmarie Gaskin, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Richard Malamut, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Emily Decroos, MD
Neurology
CMS Open Payments· $52.84 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$52.84
Total received
3
Transactions
1
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 56th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Emily Decroos do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Devon Watson, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.